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Background: Despite evidence-based guidelines informing indications for transfusions,
unwarranted variability in performance exists across cardiac surgical programs. We aimed to
identify to what extent distinguishing patient and procedural characteristics can explain centerlevel transfusion variation during coronary artery bypass grafting (CABG) surgery.
Methods: We evaluated 22,272 adult patients undergoing isolated CABG using cardiopulmonary
bypass between July 1, 2011 and July 1, 2017 across 43 centers. Iterative multilevel logistic
regression models were constructed using patient demographic, preoperative risk factors, and
intraoperative conservation strategies to progressively explain center-level transfusion variation.
Results: Nearly one-third (n=7241, 32.5%) of patients received at least one transfusion. Rates
varied between 10.9% to 59.9% across centers. Among the models explaining center-level
transfusion variability, the intraclass correlation coefficients varied between 0.072 to 0.136,
while the coefficient of variation varied between 0.29 to 0.40.
Conclusion: The results suggest that variation in center-level RBC transfusion cannot be
explained by patient and procedural factors alone. Investigating organizational culture and
programmatic infrastructure may be necessary to better understand variation in transfusion
practices.
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I. INTRODUCTION

Background and Need
Frequency of Transfusions
Allogeneic blood transfusions are considered a potentially life-saving and routine medical
procedure administered in healthcare systems around the world (Sharma et al, 2011). The
American Red Cross (2018) estimates that each donated unit of blood can save up to three lives.
A 2013 statistical brief from the Healthcare Cost and Utilization Project (HCUP) indicated that
blood transfusion was the most common all-listed procedure performed during 2010 U.S.
hospitalizations, accounting for up to eleven percent of all hospital stays with a procedure
(Pfunter et al, 2013). Despite the relatively stable rate of hospitalization over the fourteen-year
HCUP reporting period, the rate of blood transfusion in this population nearly doubled during
this time (Pfunter et al, 2013). The majority of blood collected in high and middle-income
countries are separated into components, including red blood cell (RBC) concentrates, plasma,
cryoprecipitate, and platelet concentrates (World Health Organization, 2018).
RBC transfusions are the most common blood components administered, as they are
frequently indicated to treat symptomatic anemia, acute blood loss, and inherited blood disorders
(Sharma et al, 2011). Since anemia is common complication associated with critically-ill
patients, optimizing red blood cell mass for oxygen transport and physiology is essential to
preserving adequate tissue perfusion (Arias-Morales et al., 2017). The U.S. Department of
Health and Human Services estimates that eighty-five million units of RBCs are transfused
worldwide every year (Carson, 2012), with up to fifteen million units administered in U.S.
hospitals (Bennett-Guerrero et al., 2010). Adult patients undergoing cardiac surgery are most at
risk to receive an RBC transfusion, as the level of complexity, extent of hemodilution and blood
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loss, and demographic aging may warrant transfusion (Geissler et al., 2015). Three to four
million RBC transfusions are estimated to occur across U.S. cardiac surgical programs annually
(Refaai & Blumberg, 2013), accounting for between fifteen to twenty percent of all RBC units
(Spiess, 2002; Crescenzi et al, 2012). These reported rates are not endemic to the United States.
In Australia, cardiac surgery is the second most common indication for RBC transfusion
(McQuilten et al, 2014). Similar rates have been reported from surgical programs across the
United Kingdom and other European countries (Patel & Murphy, 2018; Boer et al., 2018). A
2014 report from the Society of Thoracic Surgeons (STS) National Database indicates that the
rate of RBC transfusion for patients that received isolated coronary artery bypass graft (CABG)
surgery across participating centers was 44.5% (Bracey, 2015).

Risks of Transfusion
Mortality and Morbidity
Despite the perceived benefits of RBC transfusion, exposure to allogeneic blood products can
also be associated with risks to patient health and overall surgical outcome (Figure 1). Over the
last two decades, an increasing body of evidence has weighed the benefits and harms of
transfusion (Spiess, 2004). While nucleic acid testing has increased the safety of the blood donor
pool from viral infection, adverse events associated with immunomodulation can negatively
impact patient morbidity and mortality (Geissler et al., 2015). These transfusion-related
complications may include but not be limited to, acute injuries of the lung, kidneys, myocardium,
and systemic tissue and bloodstream infections from the transmission of microorganisms (Tempe
& Khurana, 2018).
In a retrospective cohort study of adult cardiac surgery patients, Murphy et al aimed to
analyze the association between red blood cell transfusion and clinical outcome (Murphy et al,
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2007). Primary endpoints included composite infection and ischemic outcomes (stroke, renal
injury, and myocardial infarction). Secondary end points included resource allocation, hospital
costs, and patient survival. Inclusion criteria included patients greater than sixteen years of age
that presented for cardiac surgery from April 1996 to December 21, 2003, yielding 8598 subjects
for analysis. Regression modeling was performed to quantify adjusted odds ratios for both
primary outcome measures. Subjects transfused with RBCs were 3.38 and 3.35 times more
likely than non-transfused subjects to acquire an infection or experience an ischemic event,
respectively. Additionally, patients receiving transfusion experienced a forty-two percent
increase in hospital costs, and thirty-seven percent less likelihood of surviving to hospital
discharge. Limitations of the study include the observational design and the potential bias of
sicker patients more likely to require transfusion.
Postoperative Infection
A systematic review conducted by Ang et al evaluated the association between mediastinitis
and blood transfusion in cardiac surgery. Seven studies in adult cardiac surgery published
between January 1990 and December 2010 met the inclusion criteria (Ang et al, 2012).
Exclusion criteria included patients undergoing cardiac transplant or ventricular assist device
procedures due to the associated presence of immunosuppression. Five of the studies reported an
independent association between mediastinitis and RBC transfusion. Among these, two
demonstrated a dose-dependent relationship, as an increasing exposure to RBC units increased
the likelihood of mediastinal infection. Despite these findings, the authors identified several
limitations in the review. Of the thirteen studies assessed for eligibility, there were only seven
that met the inclusion and outcome reporting criteria. Further, studies were restricted to those
published in the English language.
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Other lesser known but significant adverse clinical effects of transfusion have been reported
(Refaai & Blumberg, 2013). These would include allergic and febrile non-hemolytic reactions,
transfusion associated circulatory overload (TACO), post-transfusion purpura (PTP), and
transfusion-associated graft-versus-host disease. In patients treated with massive transfusion
protocols, secondary complications may include hyperkalemia, citrate toxicity, iron overload,
and hypothermia (Refaai & Blumberg, 2013).
End-Organ Dysfunction
Transfusion Related Acute Lung Injury (TRALI) is one of the most recognized and reported
severe transfusion reactions. From 2010-2014, the U.S. Food and Drug Administration reported
72 deaths with a positive diagnosis of TRALI (Varghese & Jhang, 2015). This represented fortyone percent of all non-infectious transfusion associated deaths. However, other pulmonary
complications from transfusion are either underreported or undiagnosed due to the incomplete
understanding of the mechanism for injury. In a prospective cohort design of two universitybased hospitals in the Netherlands, Vlaar et al reported an association between RBC transfusion
and pulmonary capillary leakage (Vlaar et al, 2012). The Pulmonary Leak Index (PLI) is an
early indicator of acute lung injury. Lower levels of pulmonary edema may manifest more
frequently than an episode of acute respiratory that would trigger a TRALI diagnosis. In this
study, a PLI was measured in all subjects that met the inclusion criteria. This included adult
elective cardiac surgical patients consenting to on-pump CABG and/or valve surgery that were
free of immunosuppressive drugs. The PLI was measured within three hours after surgery. Of
the forty patients included for study, there was a significant increase in PLI for subjects receiving
RBC transfusions versus non-transfused patients. This increase was isolated to RBC exposure,
as plasma and platelet transfusions did not significantly increase PLI values. Moreover, this
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association between PLI values and RBC units was dose dependent. Aside from the limited
sample size, the authors suggest that there may be other pathways outside of TRALI that may
contribute to depressed pulmonary function.
Acute Kidney Injury (AKI), generally defined as an abrupt decrease in renal function
characterized by a >50% increase in serum creatinine or >25% reduction in glomerular filtration
rate (GFR), may occur in more than 30% of patients undergoing cardiac surgery (Karkouti,
2012). Acute kidney injury has been associated with increases in morbidity, infection, length of
stay, and overall hospital costs (Kindzelski et al, 2018). In a review of the literature involving
cardiac surgical AKI and transfusion, Karkouti concludes that while the role of severe anemia
has been the focus of many study variables, blood transfusion also appears to be independently
associated with AKI (Karkouti, 2012). Eighteen of the twenty-two observational studies
identified in the review demonstrated a relationship between AKI and transfusion. Although the
exact nature of this relationship is not fully understood, possible causes of injury may be
attributed to the pro-inflammatory mediators that are found in allogeneic bank blood. As these
markers accumulate during storage, the resultant biochemical changes may impair oxygen
delivery and renal oxidative stress.
Research has also indicated that postoperative deep vein thrombosis (DVT) may be
associated with transfusion (Ghazi et al, 2015). Even with therapeutic thromboprophylaxis, the
rate of DVT can exceed ten percent following cardiac surgery and has been reported as high as
40% (Ghazi et al, 2015). The most commonly reported form is pulmonary embolism (PE),
which is considered life-threatening but largely preventable. In a single center retrospective
review of 1070 cardiac surgical patients, Ghazi et al found a dose-dependent response between
the incidence of postoperative DVT and RBC transfusion (Ghazi et al, 2015). The adjusted odds

6
ratio of DVT increased from 1.95 to 3.19 for patients receiving 1-3 units and ≥ 7 units of RBCs,
respectively. Silvain and colleagues performed a series of RBC transfusions in an in-vitro model
using healthy donors to determine the impact of platelet activation (Silvain et al., 2010). Using
light transmission aggregometry and flow cytometry, ABO compatible blood from transfusion
packs was mixed with whole blood from healthy donors to measure in-vitro platelet aggregation
and p-selectin expression. The significant increases observed in both platelet reactivity and pselectin release may provide an explanation of the deleterious effects of ischemia subsequent to
RBC transfusion. A similar explanation was proposed in a narrative review by Rao et al,
involving acute coronary syndrome patients with non-ST segment elevation (Rao et al (2007).
Although bleeding can be associated with an increased risk of myocardial infarction, blood
transfusions are also independently associated with ischemic events. In a review of the literature,
Dubovoy & Engoren report an increased risk venous thrombosis, stroke, and myocardial
ischemia in both cardiac surgical patients and patients diagnosed with acute coronary syndrome
(Dubovoy & Engoren, 2016).
Effects on Long-Term Outcomes
The impact of RBC transfusion can extend beyond the episode of hospitalization, affecting
both quality of life and long-term outcome. In a single-center retrospective review of 1,915
patients undergoing first-time isolated CABG, researchers aimed to determine if perioperative
blood transfusions influence long-term mortality (Engoren et al., 2002). Hospital outcome data
were matched to survival data secured through the U.S. Social Security Death Index database.
The relationship between blood transfusions (and timing) and five-year mortality was assessed.
After adjusting for comorbidities and preoperative risk factors, blood transfusions of any kind
were associated with a seventy percent risk of five-year mortality (Engoren et al., 2002). Despite
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the strong association between transfusion and survival, the authors were not able to determine
causality (Engoren et al., 2002). Other limitations of the study included the lack of reported
hemoglobin values and the inability to determine cause of reported death.
Transfusion and Resource Utilization
Exposure to allogeneic RBC transfusions may not only negatively impact clinical outcome,
but may prolong length of hospital stay, resource utilization, and costs. Galas and colleagues
analyzed the association between transfusion rate and hospital length of stay in a single center
prospective randomized controlled trial- the Transfusion Requirements After Cardiac Surgery
(TRACS) study (Galas et al., 2013). Of the enrolled 502 elective patients undergoing CABG,
valve, or CABG/valve surgery, 48% received 1-3 units of red cells, and 12% received more than
3 units. In the multivariate analysis, age, Euroscore, valvular surgery and combined procedures,
low ejection fraction, and > 3 RBC transfusions were predictive of a prolonged length of hospital
stay. The most significant limitation is the inability to explain the causal relationship between
transfusion and study endpoints.
Transfusions with allogeneic blood products also carry the burden of increased hospital costs.
The most recent National Blood Collection and Utilization Survey (NBCUS) published in 2015
reported that the median price paid by the hospital for each unit of leukocyte-reduced RBCs was
$211 (IQR $197-$228) (Ellingson et al., 2017). However, this estimate significantly
underestimates the financial impact of blood acquisition, storage, and administration. In an
activity-based cost model established across four U.S. and European acute care surgical
hospitals, Shander et al determined that the direct and indirect overhead costs ranged between
$522 and $1183 (mean $761, StdDev $294) for each unit of RBCs administered (Shander et al.,
2010). This model included all relevant personnel, capital, and consumable resources, as well as
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follow-up for acute transfusion reactions. The cost models were restricted to immediate
transfusion reactions, thus not including long-term complications or post-discharge follow-up.
These findings align with a previously published cost analysis of allogeneic transfusions in hipreplacement surgery (Blumberg et al, 1996). When accounting for outdating and wastage,
incremental nursing and clerical time, and medical coverage, each unit of blood was associated
with an incremental cost estimated between $1000 to $1500 (Blumberg et al, 1996).
With the aforementioned reported health risks and costs, clinicians must carefully weigh the
benefits and harm of exposing patients to an allogeneic transfusion. Several multi-disciplinary
clinical practice guideline documents have been developed to guide decisions in transfusion
management (Boer et al., 2018; Ferraris et al., 2011; Menkis et al., 2012; Ferraris et al., 2007).
These evidence-based recommendations identify patient blood management (PBM) strategies to
aimed to not only minimize hemodilution and surgical blood loss but reduce the incidence of
uninformed and potentially unnecessary blood transfusions. Such interventions are an essential
aspect of improving the quality of care delivered to adult cardiac surgical patients.
The Shelf Life of Allogeneic RBCs
Several large observational and meta-analyses suggest that the transfusion of older stored
blood can have a negative impact on surgical recovery and long-term survival. Depending on the
type of preservative used during blood storage, RBC shelf life may be extended to 42 days
(Buchholz et al, 1999). Although the extended lifespan of red cells would increase available
resources and reduce wastage, the biochemical changes that occur in the blood bag can have a
deleterious effect on oxygen delivery, inflammation, and infection.
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A retrospective cohort study of patients who underwent CABG, valve or combined surgery at
the Cleveland Clinic were divided into two groups according to the storage date of the RBC units
(Koch et al., 2008). Patients receiving newer blood that was less than 14 days old were
compared with patients receiving blood greater than 14 days of age. The median duration of
storage was 11 and 20 days for the newer and older blood groups, respectively. Patients that
were exposed to older blood experienced a significantly higher rate of in-hospital mortality,
mechanical ventilation time, and sepsis. These findings were supported by a recently published
retrospective review of patients who underwent either hip fracture or CABG surgery at single
center between 2008-2013 (Khan et al., 2018). In this cohort study, RBC units that were stored
for more than 28 days were associated with a higher inpatient and 30-day mortality in both
surgical groups. A larger pooled meta-analysis by Wang et al identified twenty-one studies in
cardiac and trauma surgery that examined the age of donor blood (Wang et al, 2012). Of the
nearly 410,000 total patients included for study, there was a significant association between older
blood transfusion and the risk of death that was unrelated to patient demographics or the quantity
of units transfused. Conversely, other studies have failed to demonstrate a cause and effect
relationship between RBC unit storage time and adverse outcomes out to one-year after
hospitalization (Desmarets et al., 2016; Lelubre & Vincent, 2013). Even though there may be
clear consensus regarding the safe storage age allogeneic blood, the use of autologous blood
salvage strategies has been recommended to avoid the donor storage lesions that result in red cell
deformity and impairment (Salaria et al., 2014).
Clinical Practice Guidelines and Patient Blood Management
Despite the multitude of available clinical practice guidelines, the appropriateness of
transfusion still remains in question. A 2012 national summit on overuse, organized by The
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Joint Commission and the American Medical Association, identifies unnecessary blood
transfusions as a waste of limited resource (The Joint Commission & the American Medical
Association, 2012). Overuse was defined by the committee as the provision of treatment that
provides negligible benefit to patients. Recommendations aimed to reduce overuse in blood
management included better management of anemia, identifying variability in transfusion
practice, and educating key stakeholders on the alternatives to transfusion.
While guidelines may be replete with clinical practice recommendations, their adoption
across the industry is unevenly distributed and often slow to become incorporated into clinical
practice (Committee on Quality Health Care in America, Institute of Medicine, 2001).
Following the release of the 2007 STS Blood Conservation Guidelines, a survey conducted by
Likosky and colleagues assessed the clinical practices and responses among perfusionists and
anesthesiologists across North American cardiac surgical practices (Likosky et al., 2010). Of the
1,402 surveys received from 1,061 institutions, only 20% of the respondents reported that their
institution engaged in formal discussions about the guidelines. Only 14% reported that
institutional monitoring of blood transfusions was present. Moreover, only four of the thirtyeight recommendations published in the guidelines were reported by more than five percent of
the survey respondents. The authors concluded that only minor changes to institutional blood
management programs were attributed to the guidelines. These guidelines, while intended to
provide clear and actionable recommendations to assist in practitioner decision-making, were not
being utilized to improve the effectiveness and efficiency of care. When the indications for
transfusion are not well established, significant variation may occur across clinical practice.
While the indications for transfusion are believed to be attributed to patient-related clinical
factors, practitioners may weigh these clinical characteristics differently in the absence of formal
institutional protocols. Clinical transfusion triggers may also be influenced by environmental
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factors such as computer decision support, motivation to adopt guidelines, and support for
colleagues (Sim et al, 2015). The incorporation of patient-centered blood management (PBM)
programs provide hospitals the opportunity to decrease transfusion rates, decrease practice
variation, and improve patient outcomes (Hohmuth et al, 2014).
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Problem Statement
Given the perceived benefits and risks of allogeneic RBC transfusion, the need to identify the
factors that explain variation in transfusion practice is paramount to optimize patient care and
outcome. Exposure to as little as 1 to 2 units of donor packed red blood cells has been associated
with significant increases in postoperative morbidity, mortality, and hospital costs among lowrisk coronary artery bypass grafting (CABG) procedures (Paone et al., 2014; Surgenor et al,
2006; Surgenor et al, 2009) Conventional wisdom suggests that differences in baseline patient
risk may be predominant drivers of difference in center transfusion rates in cardiac surgery.
Nonetheless, other studies suggest modifiable intraoperative factors may help explain center
performance. Few studies have empirically tested the independent effect that both pre- and
intraoperative factors have on overall RBC transfusion rates. Preoperative factors include patient
demographics, risk factors and patient comorbidities, and laboratory assays. Intraoperative
procedural variables include equipment and blood conservation modalities. Each of these
variables were identified in a consensus statement describing the minimal reporting criteria for
CPB-related red blood cell transfusions (Likosky et al, 2018).
In an observational cohort of 102,470 isolated CABG patients in the STS Adult Cardiac
Surgical database, the rate of allogeneic RBC transfusion reported between cardiac surgical
programs ranged from 7.8% to 92.8% (Bennett-Guerrero et al., 2010). After adjusting for
patient-specific risk factors, there was significant variation observed in hospital transfusion rates
regarding geographic location (P=0.007), academic status (P=0.03), and hospital volume
(P<0.001). However, these characteristics only explained 11.1% of the variation in RBC
administration. The procedural case-mix only accounted for approximately 20% of the total
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variation. As such, it remains plausible that additional variation in RBC exposure may be
attributed to the clinicians’ perceived clinical benefits of and harms of transfusion.
The variability in human behaviors around the attitudes and beliefs of transfusion exist more
broadly across international surgical programs. Snyder-Ramos et al investigated transfusion
practices across 70 surgical centers in sixteen different countries (Snyder‐Ramos et al., 2008).
The incidence of intraoperative RBC transfusion ranged from 9 to 100 percent, and 25-87% for
postoperative transfusions (Snyder‐Ramos et al., 2008). These results suggest that a clear
international consensus is necessary to identify the drivers associated with variation in RBC
transfusion.
Hospital-level variation was also described in patients undergoing major non-cardiac surgery.
In a retrospective analysis of the University HealthSystem Consortium database, Qian et al
reported a wide variability in RBC transfusions for patients undergoing total hip replacement
(THR), colectomy, and pancreaticoduodenectomy (Qian et al., 2013). Using hierarchical logistic
regression modeling with random hospital intercepts, models were formed to adjust for patientlevel demographic risk factors. Hospitals were categorized by transfusion terciles, ranging from
low to high transfusion thresholds. There was significant variability in RBC exposure, ranging
from 1.5% to 77.8% for THR surgery, 1.7% to 47.9% for colectomy, and 0% to 90.9% for
pancreaticoduodenectomies. Patients that were operated on at high transfusion centers were 2.4
times more likely to receive RBC units than patients at average transfusion centers. Conversely,
patients at low transfusion programs were about 50% less likely to receive allogeneic RBCs.
The combined results from each of these three studies strongly suggest that variances in RBC
transfusion may be attributed to factors beyond patient demographics and disease characteristics
(Bennett-Guerrero et al., 2010; Snyder‐Ramos et al., 2008; Qian et al., 2013). These differences

14
also do not appear to be attributed to institutional procedural case-mix or hospital characteristics.
For these reasons, we examine patient and procedural determinants of center-level variation in
perioperative transfusions in the setting of CABG surgery.

Research Hypothesis
The primary aim of this research project is to identify to what extent distinguishing patient
and procedural characteristics that are known prior to allogeneic RBC transfusion can explain
center-level variation in transfusion rates across adult isolated coronary artery surgical
procedures. It is hypothesized that variation in center-level transfusion rates may be explained by
patient and procedural risk factors that are known prior to the initiation of cardiopulmonary
bypass (CPB).

II. LITERATURE REVIEW
Anemia vs Transfusion
Although the risks and adverse effects of allogeneic RBC transfusion are well-described in
the literature, severe anemia has also been associated with increased surgical morbidity and
mortality. Anemia is broadly described as reduced levels of hemoglobin (Hgb) that impair
oxygen delivery and induce tissue hypoxia (Dhir & Tempe, 2017). In a review article weighing
the importance of anemia avoidance in blood management programs, Dhir & Tempe report the
incidence of anemia in cardiac surgery over 30% (Dhir & Tempe, 2017). Patients with low
perioperative Hgb content were more likely to experience perioperative complications and allcause mortality. These harmful effects of anemia not only translated into a reduced carrying
capacity for oxygen but are also attributed to impairments of the rheological characteristics of
circulating blood, exacerbation of chronic illness and inflammation, and increased tissue
ischemia (Lobel et al, 2015). These impairments may lead clinicians to question whether anemia
or transfusion contributes more to an adverse outcome. To what degree of anemia is safe for
patients to reduce the exposure to allogeneic blood? Moreover, what effect would both anemia
and RBC transfusion have on overall patient care and outcomes?
Engoren et al conducted a single-center retrospective cohort study of 922 patients who
underwent isolated CABG surgery (Engoren et al, 2014). The study aim was to determine
whether preoperative anemia (defined as < 12g/dl for men; < 11g/dl for women) would
significantly interact with allogeneic RBC transfusions. Receiving a transfusion for anemia
would either provide a protective or harmful effect on patient survival out to four years. Four
groups were assigned from the study population, each describing the exposure to anemia and
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blood transfusion. A subsequent analysis included a propensity match to control for all variables
except for anemia and transfusion. The results indicated that the interaction of both anemia and
transfusion was associated with nearly three-fold greater hazard of dying (HR = 2.918, 95% C.I
= 1.512-5.633, p = 0.001). Additionally, patients that experienced both anemia and transfusion
had twice the hazard of dying as those who experienced anemia but not transfusion (HR = 2.087,
95% C.I. = 1.004-4.336, p = 0.049). Similar findings were observed in the propensity scoring
analysis, as anemic subjects transfused with blood had a significantly higher hazard of mortality.
Limitations in the study included the single-center observational design, transfusion of RBCs
using hemoglobin triggers only, and the power insufficiency to detect all of the adverse effects of
anemia alone. The authors concluded that the exposure to transfusion created the greatest risks
of postoperative mortality, in both anemia and non-anemic populations.
Lapar and colleagues undertook an observational analysis of 33,411 patients undergoing
isolated CABG surgery between January 2007 to December 2017 at any of 19 cardiac surgical
centers participating in the Virginia Cardiac Surgical Quality Initiative (VCSQI) Registry. The
investigators used hierarchical logistic regression modeling to determine the relationship
between preoperative hematocrit (HCT) and RBC transfusion and the effects on morbidity and
mortality (Lapar et al., 2018). Generalized linear mixed regression was used to estimate the
effects between the model covariates baseline HCT and PRBC transfusion on the outcome
variable, major morbidity and mortality. The mean baseline preoperative HCT was 39.1% (3642%), and the STS predicted risk of mortality was 1.8 +/- 3.1%. After adjusting for patient risk,
exposure to RBC transfusions was associated with an increased odds of mortality (OR- 4.3; P <
0.001), renal failure (OR-6.3; P = 0.0001), and postoperative stroke (OR- 2.4; P < 0.0001).
While these associations with morbidity were not as strong using HCT, a 1-point increase in
preoperative HCT was attributed to a decreased odds of mortality (OR, 0.97; P= 0.0001) and
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renal failure (OR, 0.94; P < 0.0001). The investigators concluded that RBC transfusion had a
higher association with morbidity and mortality than with the continuous nonlinear relationship
to preoperative HCT alone, thus supporting the proposal that efforts be made in decreasing the
incidence of ‘unnecessary’ allogeneic blood transfusions. Modifiable risk factors such as
limiting systemic hemodilution and avoiding anemia should be considered. Aside from the
observational nature of the study design, there were several other limitations to the findings.
First, not all adverse outcome variables were identified in the endpoints. Events such as TRALI,
infection, or transfusion reaction were not reported. The changes in perioperative HCT were also
not recorded, so the impact that nadir HCT and average HCT values has on both RBC
transfusion and outcome were not included for study.
The implications and management of anemia in cardiac surgery were described in a literature
review by Loor et al (Loor et al, 2012). Given the negative consequences that both anemia and
allogeneic transfusion have on outcome, strategies should be considered to optimize hemoglobin
levels prior to surgery. One strategy would be to delay elective operations for patients presenting
with anemia. Other interventions identified included iron supplementation, diuresis, and the
avoidance of specific types of platelet inhibitors prior to surgery. Figure 2 is a composite graph
summarizing the effects of preoperative anemia on postoperative outcome (Loor et al, 2012).
Intraoperative strategies that aim to minimize surgical blood loss, limit systemic hemodilution,
and maximize autologous red blood cell recovery have also been demonstrated to reduce the
incidence the consequences of anemia (Figure 3) (Goldberg et al, 2016; Loor et al, 2012).
Liberal vs Restrictive Transfusion
Navigating through the paradox that exists between the unfavorable outcomes from both
anemia and transfusion can be a challenge for surgical care teams. Traditional protocols
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previously supported the transfusion of patients when the hemoglobin level dropped below
10g/dl (Adams & Lundy, 1942). As the risks associated with transfusion became more evident,
several published guidelines have advocated for a more restrictive approach blood transfusion.
Additional consensus statements have also recommended against a single criterion to transfuse
patients (Carson et al, 2002). Best practices in blood management would incorporate laboratory
and physiologic markers in the decision-making process.
In 1999, a landmark multicenter, prospective, randomized trial was published describing the
two different transfusion thresholds for critical care patients in Canada (Hebert et al., 1999).
Previous randomized controlled trials had been conducted on blood transfusion practices;
however, a multicenter design involving critically-ill patients had not yet been reported. Critical
care patients who presented with a hemoglobin less than 9.0 g/dl within 72 hours of admission
were randomized into either a liberal RBC transfusion protocol (Hgb 10-12 g/dl, n=420 pts.) or a
restrictive transfusion protocol (Hgb 7-9 g/dl, n=418 pts.). Patients were prospectively followed
to determine all-cause death at 30 days, hospital mortality rates, organ dysfunction, and intensive
care unit and hospital length of stay. Overall 30-day mortality was not different between the two
groups (18.7% vs 23.3%, p=0.11). Acute Physiology and Chronic Health Evaluation (APACHE)
II scores significantly favored the restrictive group over the liberal group (8.7% vs 16.1%,
p=0.03), respectively. The restrictive group also experienced a significantly lower hospital
mortality rate than the liberal group (22.2% vs 28.1%, p=0.05). However, there was no
significant differences in outcome noted in patients diagnosed with cardiac disease. Hebert and
colleagues concluded that a restrictive approach to RBC transfusion is at least as safe and
possibly superior to a liberal strategy in critical care patients without unstable angina (Hebert et
al, 1999).
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In another multicenter randomized trial, 5,243 patients undergoing cardiac surgery (TRICS
III Clinical Trial) were prospectively assigned to a liberal or a restrictive transfusion protocol
immediately before surgery (Mazer et al., 2017). The threshold for liberal transfusion was a Hgb
below 9.5 g/dl in the operating room and intensive care unit (ICU), or a Hgb below 8.5 g/dl in
the postoperative telemetry ward. Restrictive threshold subjects were transfused if the Hgb was
below 7.5 g/dl at any point of care. The primary endpoints for this non-inferiority study design
was all-cause death, MI, stroke, and post-operative renal failure requiring dialysis. Secondary
outcomes included RBC transfusion and other clinical markers. Patients were enrolled for study
across 73 sites in 19 countries. These were patients considered at moderate to high risk of death,
as defined by the Euroscore I score. After study withdrawal and exclusions, 5092 patients
entered the modified intention-to-treat population, and 4860 patients were included for perprotocol analysis. Among these patients, 26.1% received CABG only, 27.7% had CABG with
another procedure, and 46.2% underwent a non-CABG procedure. The overall mean Hgb value
at study baseline was 13.1 +/- 1.8 g/dl. The results indicated that a restrictive transfusion
strategy was not inferior to a liberal threshold. While there were no significant differences noted
in primary outcomes, RBC transfusion occurred in 52.3% of the restrictive group and 72.6% in
the liberal threshold group (OR, 0.41; 95% CI, 0.37 to 0.47). A subgroup analysis also
demonstrated a significant benefit in outcome for restrictive group among 75 years of age or
greater (OR, 0.70; 95% CI, 0.54 to 0.89). These findings suggest that a restrictive transfusion
protocol can be implemented safely in cardiac surgical patients that have a predicted moderate to
high risk of hospital death.
Murphy et al conducted a multicenter transfusion threshold across 17 cardiac surgical
programs in the United Kingdom (Murphy et al, 2015). In this study, adult patients were
prospectively enrolled into a liberal (< 9g/dl) or a restrictive threshold (< 7.5 g/dl) once the Hgb
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decreased < 9.0 g/dl following cardiac surgery. The primary outcomes were serious infection
and ischemic events. All-cause mortality and hospital index costs were also estimated out to 90
days after surgery. A total of 2003 patients were randomized and included for analysis.
Transfusion rates after randomization were 53.4% and 92.2% for the restrictive and liberal
groups, respectively. The results from this study differ from other reported transfusion threshold
trials, as a restrictive transfusion was not found to be equivalent to a liberal approach. There was
a significant increase in deaths in the restrictive vs liberal group, 4.2% vs 2.6%, respectively (P =
0.045). There was also a reduction in primary outcome events favoring the liberal group, but this
did not reach statistical significance. The discrepancy in these findings may be attributed to
several key study limitations. Randomization in the trial did not take place until the
postoperative period. Many of the patients were exposed to allogeneic transfusions prior to
enrollment. Mortality was indicated as a secondary outcome (which was added after the trial
began). Using the intention-to-treat protocol, the authors reported relatively high rates of
nonadherence, 30% and 45.2% for the restrictive and liberal threshold groups, respectively.
Further, severe nonadherence (significant enough to change the classification of the subject), was
observed in 9.7% and 6.2% in both groups.
A 2017 meta-analysis of restrictive versus liberal transfusion strategies was conducted by
Shehata et al to measure all-cause mortality and secondary clinical outcomes among adult and
pediatric patients that underwent cardiac surgery (Shehata et al, 2018). Of the thirteen trials
included for analysis (8 adult studies), 4545 patients were assigned do the restrictive group and
4547 patients were assigned to the liberal strategy. There were no significant differences
observed in the relative risks associated with mortality, myocardial infarction, stroke, renal
failure, or infection (Figure 4) (Shehata et al, 2018). Despite the lack of a subgroup analysis
comparing high risk and low risk cardiac surgery patients and the pooling of adult and pediatric
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cardiac procedures, a restrictive RBC transfusion strategy was not inferior to a liberal threshold
protocol.
Predictors of Transfusion
Models that can accurately predict a patient’s risk of receiving a perioperative blood may
help facilitate appropriate blood management techniques. A preoperative patient risk
stratification would not only allow clinicians to identify those patients considered at high risk of
transfusion, but such a scoring system may also recognize an individual’s risk for potentially
discretionary 1-2 RBC unit allocations. Prediction modeling can be used to inform treatment
decisions.
Moskowitz et al conducted an observational study of 307 consecutive patients undergoing
CABG, valve, or combined procedures at a single cardiac surgical center (Moskowitz et al,
2004). Using a multivariate analysis of preoperative patient risk factors, patients with a
calculated transfusion probability of at least 5% were used to identify intraoperative predictors.
Preoperative independent transfusion predictors included red blood cell mass, surgery type,
procedural status, number of diseased vessels, serum creatinine, and preoperative thrombin time.
Intraoperative factors included CPB time, number of CABG grafts, amount of acute
normovolemic hemodilution (ANH) blood harvested, and total crystalloid volume. The overall
rate of perioperative transfusion was 13%. Applying the formula to a validation group of 246
subjects resulted in a predicted risk of transfusion range from 0.01% to 90%, with median and
mean values of 4% and 12%, respectively. Fourteen percent of the patients received a blood
transfusion. One of the most significant limitations of these findings was the small number of
subjects used for both the prediction formula and validation. Moreover, the overall transfusion
rate of 11% observed in the preoperative risk factor multivariate analysis may not have been
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large enough of an exposure to capture all of the conventional factors commonly associated with
blood transfusion.
In a multicenter regional perfusion outcome registry study of 20,377 adult CABG patients,
Likosky et al identified preoperative factors to develop a prediction model for RBC transfusion
(Likosky et al, 2017). Variables used in the univariate analysis included patient demographics,
medical history, procedural status, admission status, comorbidities, cardiac anatomy, and
institutional demographics. The population was divided into the development and validation
samples to create the multivariate model and assess model fit and discrimination. The sixteen
variables that were included in the model were age, gender, race, body surface area (BSA), last
pre-op HCT, preoperative total albumin, last preoperative creatinine, congestive heart failure,
dialysis, history of cerebrovascular disease, peripheral artery disease, previous cardiac surgery,
three vessel disease, ejection fraction, acuity, and year of surgery. The final prediction model
discriminated well and achieved satisfactory correlation (ROCdevelopment: 0.81; ROCvalidation: 0.82).
Among the observed limitations were the inability to discriminate between the number of
exposed RBC units administered, the lack of inclusion of non-red cell blood products, and the
homogeneity in the study population according to surgery type and region. The authors
recognize the importance of conducting an external validation against a larger and more diverse
population of surgical patients.
Two other risk prediction score models were developed and compared to three previously
existing scores (Goudie et al., 2015). Clinical data collected from 27 cardiac surgical programs
from the U.K and Europe were used to create prediction models for exposure to RBC
transfusions and for large amount transfusion volumes (≥4 RBC units). These resultant risk
models were compared to the Transfusion Risk and Clinical Knowledge Score (TRACK), the
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Transfusion Risk Understanding Scoring Tool (TRUST), and the Papworth Bleeding Risk Score
(BRiSc). The receiver operating characteristic curve demonstrated agreement (AUC = 0.77,
95% CI, 0.77-0.77) for any RBC exposure, and for large blood volume scores (AUC = 0.80, 95%
CI, (0.79-0.80). The AUC values for the TRACK and TRUST scores any for any RBC exposure
were 0.71 and 0.71, respectively. The AUC for the LVBT and BRiSc score was 0.69. These
findings suggest that transfusion risk models can effectively discriminate in patient transfusion
risk stratification (Goudie et al, 2015). This may further inform clinical decision making and
encourage evidence-based blood management practices.
Multidisciplinary Teams in Blood Management
As the pursuit for patient-centered blood management programs continues to expand across
the cardiac surgical community, the importance of optimizing multidisciplinary team
collaboration cannot be overstated. There is clear consensus that a multidisciplinary approach
involving institutional key stakeholders improves both the process of care and surgical outcome
in blood conservation programs. The 2011 Update Society of Thoracic Surgeons and Society of
Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines identifies the
following recommendation with the highest level of support (Ferraris et al., 2011):
A multidisciplinary approach involving multiple stakeholders, institutional support,
enforceable transfusion algorithms supplemented with point-of-care testing, and all of
the already mentioned efficacious blood conservation interventions limits blood
transfusion and provides optimal blood conservation for cardiac operations. (Class ILevel of evidence A)
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In addition to surgeons and anesthesiologists, clinical perfusionists were key contributors to this
practice guideline revision. The authors concluded that when supported with guidelines and
institutional protocols, multidisciplinary teams make better decisions in the management of
blood resources.
The taskforce on patient blood management for adult cardiac surgery established by the
European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of
Cardiothoracic Anesthesia (EACTA) support the team approach to treat anemia, identifying
cardiologists, surgeons, anesthesiologists and perfusionists as key stakeholders with the
following recommendation (Boer et al., 2018):
It is recommended that the members of the multidisciplinary team discuss the optimal
surgical strategy based on clinical status, comorbidities, bleeding risk and team
expertise. (Class I, Level of Evidence C)
Both the STS and EACTS documents emphasize the importance of team effort and collaboration
in blood management. Numerous professional disciplines across the continuum of care should
serve as key stakeholders in developing effective blood management programs. Presumably,
both the strength and implementation of these guidelines may be extended through collaborations
with other professional societies.
Support for team-approached blood management also exists in professional practice
standards and guidelines. The 2017 update to the American Society of Extracorporeal
Technology (AmSECT, 2017) identifies the minimum practice standards and recommendations
the membership believe support reliable, safe, and effective perfusion blood management
programs. Among the recommendations in Guideline 13.1 are the following (AmSECT, 2017):

25
- Participate in pre-operative briefings (discussions) with the surgical care team
(Standard 5.1) regarding transfusion strategies and target hematocrit values.
- Participation in a multidisciplinary blood management team.
Properly leveraging multidisciplinary teams across the surgical program starts with capturing
clinical data and outcome measures. In an observational review of a multi-institutional clinical
perfusion database, Likosky et al describe the value that clinical registries may have in
identifying practice variation relative to published clinical practice guidelines (Likosky et al,
2016). Specifically, the review aimed to understand center-level variation of two blood
conservation strategies, Retrograde autologous priming (RAP), and acute normovolemic
hemodilution (ANH). The 2011 STS/SCA Update assigned a Class IIB, Level of Evidence B
recommendation for both of these blood management techniques (Ferraris et al., 2011). The IIb
designation suggests these interventions may be considered but their overall effectiveness is
unclear. Using the Perfusion Measures and Outcomes (PERForm) registry, the authors identified
the reported use in CABG surgery across 27 contributing centers over a four-year period. The
overall use of ANH was reported at 11.6% (0 - 75.7%), and the employment of RAP was 71.4%
(0 – 99%). Despite a similar level of evidence in the 2011 update, a significant difference was
observed in practice adoption. The use of the database not only helped identify center-level
practice variation, but such systems may better explain variability in RBC transfusion rates.
Organizational Culture and Non-Technical Drivers of Transfusion
Previous literature has identified both modifiable and non-modifiable clinical factors
associated with the increased exposure to allogeneic RBC units (Shaw et al, 2015; Cote et al,
2015; Shehata et al, 2007). Additional investigation into nonclinical factors (e.g., provider
transfusion triggers, organizational culture, blood management protocols) may improve our
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understanding of center-level differences (Camaj et al, 2017). Organizational culture, broadly
defined as the basic assumptions and values that guide organizations may be associated with
variances in clinical practice (Schneider et al, 2013). Using multilevel mixed-effect logistic and
linear regression models, Jin et al examined variation in blood transfusion practices among 5,744
isolated CABG procedures performed by 42 surgeons at 12 hospitals within the same health
system (Jin et al, 2013). Observed variances in RBC transfusions at the hospital level (0.82)
were over twice as high as surgeons practicing at the same hospital (0.35), suggesting a
correlation between organizational culture and transfusion practice through factors such as team
familiarity, quality improvement and data sharing, and standardized clinical practices (Jin et al,
2013).
Likosky et al compared perioperative RBC transfusion rates for both CABG and
percutaneous coronary intervention (PCI) at 33 Michigan cardiac surgical programs (Likosky et
al, 2013). While perhaps somewhat surprising, the investigators found that an institution’s
CABG transfusion rate was significantly correlated with its PCI rate. Both crude (0.48, p=.005)
and adjusted (0.53, p=.001) RBC transfusion correlations between CABG and PCI existed
independent of patient case mix. These findings suggest that factors beyond patient-level risk
(e.g., transfusion protocols, practice patterns, organizational culture) may help explain centerlevel differences in transfusion practices.
A retrospective single center analysis of 4,823 patients by Cote et al found that differing
practice patterns among cardiac surgeons and anesthesiologists were independent predictors of
perioperative transfusion (Cote et al, 2015). Patients who underwent off-pump or emergency
surgery were excluded from analysis. The surgical team consisted of 5 attending surgeons, 7
anesthesiologists, and 7 perfusionists. The primary outcome of interest was transfusion, defined
as at least 1 unit of blood (RBC, fresh frozen plasma, cryoprecipitate, platelets, or factor 8
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inhibitor bypass activity) administered within the first 24 hours after surgery. The overall rate of
blood transfusion was 40%. Significant variation was observed between surgeons (32.4% to
51.5%, p<.0001) and anesthesiologists (34.4% to 51.9%, p<.0001). There were also significant
differences in transfusion rates across the reporting year, from 28.2% in 2004 to 48.8% in 2008.
After adjusting for pre- and intraoperative variables, physician and year of procedure contributed
to variation in blood transfusion rates.

III. METHODOLOGY
Study Design and Hypotheses
We evaluated determinants of center variability in intra-or postoperative RBC transfusion
rates across adult cardiac surgical programs performing isolated CABG surgery. The primary
aim was to identify determinants of center variability in allogeneic RBC transfusions following
adult isolated coronary artery surgical procedures.

Patients and Methods
This study (HUM00151098) was approved by the University of Michigan’s Institutional
Review Board.
The PERFusion measures and outcomes (PERForm) registry was established in 2010 as a
voluntary database. Current efforts are focused on identifying perfusion practices associated with
improved outcomes and providing benchmarking opportunities to support local and multiinstitutional quality improvement initiatives. The PERForm registry is structured within the
Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative (MSTCVSQC), a cardiac surgeon–led quality collaborative embedded in the Michigan Society of Thoracic
and Cardiovascular Surgeons. The membership of the MSTCVS-QC, which became partially
funded by Blue Cross/Blue Shield of Michigan in 2005, convenes quarterly to review processes
and outcomes and to facilitate and evaluate quality improvement studies. All programs in the
MSTCVS-QC use The Society of Thoracic Surgeons (STS) data collection form and submit data
on a quarterly basis to both the STS database and the MSTCVS-QC data warehouse. The
PERForm registry complements data from the STS by focusing on the care and conduct of
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cardiovascular perfusion practices (The Michigan Society of Thoracic Cardiovascular Surgeons
and The MSTCVS Quality Collaborative, 2018). Each record from the PERForm registry is
merged with a record from each center’s surgical data (Paugh et al., 2012).
The study population included adult patients undergoing isolated CABG surgery using CPB
support between July 1, 2011 and July 1, 2017. Data were collected from 43 cardiac surgical
centers participating in both the Society of Thoracic Surgeons Adult Cardiac Surgery Database
(STS-ACSD) and the PERForm registry. After exclusions (Figure 5), our final dataset included
22, 272 patients.
The primary outcome is allogeneic RBC transfusions administered during the intraoperative
and/or postoperative periods.

Statistical Analysis
We considered possible variables that are present prior to at the time of an RBC transfusion
decision. For instance, we considered patient and disease characteristics, equipment selection,
laboratory assay results, and intraoperative blood conservation strategies.
We performed median and mode imputation for continuous and categorical covariates with
an observed data missingness of less than 10% to ensure that all hospitals were included during
the modeling process. Specifically, missing preoperative risk factor data variables such as CHF,
diabetes, history of cerebrovascular disease, peripheral arterial disease, dialysis status, and prior
myocardial infarction were imputed as no disease. Missing data for operative status was
considered as elective surgery. Missing data fields including last preoperative hematocrit and
serum creatinine levels were imputed to their conditional median on gender. Variables with a
higher than 10% missingness remained by creating missing indicators.
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The distribution of demographic variables was reported according to quartile categories of
crude transfusion rates. The observed-to-expected (OE) ratio for perioperative RBC transfusion
was calculated using the observed rates from the data and the expected rates derived from the
risk prediction model previously described by Likosky et al (Likosky et al., 2017).
To quantify the degree to which hospitals, patient and procedural factors influence variation
in center-level transfusion rates, a series of mixed effect logistic regression models (Model 1-4)
were constructed (Table 1):
-

Model 1: No covariates- contain only hospital random intercepts.

-

Model 2: Model 1 + Preoperative patient demographics, risk factors,
comorbidities, and laboratory values.
o Patient demographics: age (yrs), gender, body surface area (m2) &
admission status (elective, urgent, emergent/salvage).
o Patient comorbidities and risk factors: chronic lung disease (y/n), diabetes
mellitus (y/n), cardiogenic shock (y/n), cerebrovascular disease (y/n),
peripheral artery disease (y/n), dialysis (y/n), three vessel disease (y/n),
reoperative status (y/n), previous MI (y/n), left ventricular ejection
fraction (EF), current smoker (y/n), anticoagulation medications < 48 hrs
(y/n), hypertension (y/n).
o Laboratory assay values: preoperative HCT (%), platelet count (x10000),
serum albumin (g/dl), serum creatinine (mg/dl).

-

Model 3: Model 1 + intraoperative blood conservation strategies
o Perfusion equipment: arterial roller pump (y/n), cardioplegia type (% of
cases w/non-traditional blood based cardioplegia- del Nido),
autotransfusion usage (y/n)
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o Fluid management: autologous CPB circuit prime (y/n), acute
normovolemic hemodilution (y/n), CPB net prime volume (indexed to
BSA, ml/m2)
-

Model 4: Model 1 + Model 2 + Model 3

From each model, the random effect variance on the logit scale was computed and intraclass
correlation coefficient (ICC) is calculated using both the simulation method and latent variable
method as described by Merlo et al (Merlo et al., 2006) . In Model 1 with only hospital random
effect, ICC is the proportion of total observed variance in transfusion that is attributable to the
systematic differences between hospitals. In Models 2-4 with covariates adjustment, the ICC is
interpreted as the proportion of the residual variation after accounting other variables in the
model that is attributable to the hospital differences. Continuous variables are presented as
median and interquartile range (25th, 75th percentile), and categorical variables are presented as
counts and percentages. Pearson’s Chi-Square and Fisher’s Exact tests were performed for
categorical variables, as appropriate, and the Wilcoxon rank-sum test was performed for
continuous variables. A p value less than 0.05 was considered for all two-tailed significance
testing. Statistical analysis was conducted using SAS version 9.4 (SAS Institute, Cary, NC) and
R version 3.5.2.

IV. ARTICLE MANUSCRIPT

DETERMINANTS OF HOSPITAL VARIABILITY IN PERIOPERATIVE RED BLOOD
CELL TRANSFUSIONS DURING CORONARY ARTERY BYPASS GRAFT SURGERY

Abstract

Background: Despite the continued emergence of clinical practice guidelines describing the
indications for allogeneic RBC blood transfusion, wide variability in transfusion rates persist
across cardiac surgical programs. While the determinants underlying this variability include
patient and procedural-related factors, evaluation of these key factors has not been fully
explored. With this in mind, we aimed to identify to what extent distinguishing patient and
procedural characteristics can explain center-level RBC transfusion variation during coronary
artery bypass grafting (CABG) surgery.
Methods: 22,272 adult patients undergoing isolated CABG using CPB support between July 1,
2011 and July 1, 2017 were included for analysis using the PERFusion measures and outcomes
(PERForm) registry. Iterative multilevel logistic regression models were constructed using
patient demographic, preoperative risk factors, and intraoperative conservation strategies to
progressively explain center-level RBC transfusion variation.
Results: 7241 (32.5%) of the 22,272 study subjects received at least one unit of allogeneic RBCs
(10.9% - 59.9%). When compared to subjects who were not transfused, patients that received at
least one unit of RBCs were older (68 vs 64 years, p<0.001), female gender (41.5% vs 15.9%,
p<0.001), lower BSA (1.93m vs 2.07m , p<0.001), and less likely to be electively admitted for
2
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surgery (34.5% vs 42.1%), respectfully. Among the models explaining center-level transfusion
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variability, the Intraclass correlation coefficients (ICC) were 0.07 for Model 1 (hospital random
intercepts only), 0.12 for Model 2 (patient factors+ Model 1), 0.14 for Model 3 (intraoperative
factors+ Model 1), and 0.11 for Model 4 (Models 1 + 2 +3). The coefficient of variation for
center-level transfusion rates by model were 0.31, 0.29, 0.40 and 0.30 for models 1 through 4,
respectively. The majority of center-level variation could not be explained through the combined
models.
Conclusion: The results suggest that variation in center-level RBC transfusion cannot be
explained by patient and procedural factors alone. Investigating organizational culture and
programmatic infrastructure may be necessary to better understand variation in transfusion
practices.
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Approximately 85 million allogeneic red blood cell (RBC) units are administered
worldwide every year, with cardiac surgery accounting for 15 to 20% of all transfusions (1-3).
Almost half of all patients undergoing isolated coronary artery bypass grafting (CABG) receive
at least one RBC unit during the hospital episode of care (4). Despite the perceived clinical
benefits in treating symptomatic anemia and hemorrhage, exposure to as little as one or two RBC
units has been independently associated with significantly increased postoperative morbidity and
mortality following CABG surgery (5).
Several randomized controlled trials and metanalyses have suggested that that a more
‘restrictive’ strategy for RBC exposure may be noninferior to a liberal transfusion threshold (68). Current multidisciplinary clinical practice guidelines identify interventions aimed to reduce
bleeding and unnecessary blood transfusions in cardiac surgery (9-11). While guidelines may
provide practical recommendations for institutional blood conservation programs, their
dissemination and direct impact on clinical care may not be fully realized (12). Wide variation
in blood transfusion rates has been reported across institutions even after adjusting for patient
risk (13, 14). Prior work has identified hospital geographic location, academic status, surgical
case volume, and procedural mix as risk factors for transfusion (15). Few studies have
empirically tested the independent effect that both pre and intraoperative factors have on blood
transfusion rates prior to the initiation of cardiopulmonary bypass (CPB). As such, determinants
of center-level variation in RBC rates have not been explained.
We evaluated determinants of center variability in intra-or postoperative RBC transfusion
rates across adult cardiac surgical programs performing isolated CABG surgery. The primary
aim is to identify to what extent distinguishing patient and procedural characteristics that are
known prior to allogeneic RBC transfusions may help explain center-level variation in
transfusion rates across adult isolated coronary artery surgical procedures.
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Patients and Methods
This study (HUM00151098) was approved by the University of Michigan’s Institutional
Review Board.
The PERFusion measures and outcomes (PERForm) registry was established in 2010 as a
voluntary database. Current efforts are focused on identifying perfusion practices associated with
improved outcomes and providing benchmarking opportunities to support local and multiinstitutional quality improvement initiatives. The PERForm registry is structured within the
Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative (MSTCVSQC), a cardiac surgeon–led quality collaborative embedded in the Michigan Society of Thoracic
and Cardiovascular Surgeons. The membership of the MSTCVS-QC, which became partially
funded by Blue Cross/Blue Shield of Michigan in 2005, convenes quarterly to review processes
and outcomes and to facilitate and evaluate quality improvement studies.
All programs in the MSTCVS-QC use The Society of Thoracic Surgeons (STS) data
collection form and submit data on a quarterly basis to both the STS database and the MSTCVSQC data warehouse. The PERForm registry complements data from the STS by focusing on the
care and conduct of cardiovascular perfusion practices (16). Each record from the PERForm
registry are merged with a record from each center’s surgical data (17) .
The study population included adult patients undergoing isolated CABG surgery using
CPB support between July 1, 2011 and July 1, 2017. Data were collected from 43 cardiac
surgical centers participating in both the Society of Thoracic Surgeons Adult Cardiac Surgery
Database (STS-ACSD) and the PERForm registry. Each surgical record was merged with the
perfusion record from the PERForm registry. After exclusions (Figure 1), our final dataset
included 22, 272 patients.
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The primary outcome is allogeneic RBC transfusions administered during the
intraoperative and/or postoperative periods.

Statistical Analysis
We considered possible variables that are present prior to at the time of an RBC
transfusion decision. For instance, we considered patient and disease characteristics, equipment
selection, laboratory assay results, and intraoperative blood conservation strategies (Figure 2).
We performed median and mode imputation for continuous and categorical covariates
with an observed data missingness of less than 10% to ensure that all hospitals were included
during the modeling process. Specifically, missing preoperative risk factor data variables such
as diabetes, history of cerebrovascular disease, dialysis status, and prior myocardial infarction
were imputed as no disease. Missing data for operative status was considered as elective
surgery. Missing data fields including last preoperative hematocrit and serum creatinine levels
were imputed to their conditional median on gender. Variables with a higher than 10%
missingness such as CHF and PVD remained by creating missing indicators.
The distribution of demographic variables was reported according to quartile categories
of crude transfusion rates. The observed-to-expected (OE) ratio for perioperative RBC
transfusion was calculated using the observed rates from the data and the expected rates derived
from the risk prediction model previously described by Likosky et al (18).
To quantify the degree to which hospitals, patient and procedural factors influence
variation in center-level transfusion rates, a series of mixed effect logistic regression models
(Model 1-4) were constructed (Figure 2). This approach is similar to a model previously
reported by Xian et al (19). Model 1 contained hospital random intercepts and no covariates.
Model 2 included the previous Model 1 hospital random effect plus patient-related risk factors:
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patient demographic data (age, gender, body surface area, admission status), preoperative
laboratory serum assay results (hematocrit, platelet count, albumin level, serum creatinine), and
preoperative risk factors (smoking status, cardiac history, lung disease, cerebrovascular disease,
hypertension, peripheral vascular disease, diabetes, preoperative dialysis, anticoagulant
medications within 48 hours). Model 3 contained Model 1 plus intraoperative blood
conservation techniques and equipment aimed to reduce hemodilution and anemia (arterial roller
head usage, autotransfusion usage, autologous CPB circuit priming, acute normovolemic
hemodilution, del Nido cardioplegia usage, CPB net crystalloid volume indexed to patient BSA).
Model 4 included all of the previous models of 1 through 3. Patient and procedural covariates
were selected according to the consensus minimal reporting criteria for CPB-related RBC
transfusions reported by Likosky et al (20).
From each model, the random effect variance on the logit scale was computed and
intraclass correlation coefficient (ICC) is calculated using both the simulation method and latent
variable method as described by Merlo et al (21). In Model 1 with only the hospital random
effect, the ICC is the proportion of total observed variance in transfusion that is attributable to
the systematic differences between hospitals. In Models 2-4 with covariate adjustment, the ICC
is interpreted as the proportion of the residual variation after accounting other variables in the
model that is attributable to the hospital differences. Continuous variables are presented as
median and interquartile range (25th, 75th percentile), and categorical variables are presented as
counts and percentages. Pearson’s Chi-Square and Fisher’s Exact tests were performed for
categorical variables, as appropriate, and the Wilcoxon rank-sum test was performed for
continuous variables. A p value less than 0.05 was considered for all two-tailed significance
testing. Statistical analysis was conducted using SAS version 9.4 (SAS Institute, Cary, NC) and
R version 3.5.2.
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Results
Table 1 describes patient demographic and procedural variables according to
perioperative RBC transfusion. There were 7241 (32.5%) of the 22,272 study subjects that
received at least one unit of allogeneic RBCs. Among those, 3,884 (53.6%) subjects were
transfused in the postoperative period only. Overall, the median age was 65 years (IQR 58, 72),
with males comprising 75.8% of the population. Arterial rollerheads were used in 44.5% of
procedures, and 14.6% utilized del Nido cardioplegia solution. When compared to subjects who
were not transfused, patients that received at least one unit of RBCs were older (68 vs 64 years,
p<0.001), female sex (41.5% vs 15.9%, p<0.001), lower BSA (1.93m2 vs 2.07m2, p<0.001), and
less likely to be electively admitted for surgery (34.5% vs 42.1%), respectfully. The transfusion
group also had a significantly higher prevalence of preoperative risk factors including previous
MI (60.1% vs 51.5%, p<0.001), chronic lung disease (13.5% vs 8.5%, p<0.001), congestive heart
failure (14.5% vs 9.6%, p<0.001), peripheral vascular disease (16.1% vs 11.6%, p<0.001),
cardiogenic shock (3.3% vs 0.9%, p<0.001), preoperative dialysis (6.2% vs 0.7%, p<0.001),
diabetes (52.5% vs 44.9%, p<0.001), cerebrovascular disease (28.4% vs 17.4%, p<0.001), and
anticoagulant medication within 48 hours of surgery (50.7% vs 44.0%, p<0.001). Similar
differences between groups were also observed across all perioperative HCT values;
Preoperative HCT (35.9% vs 41%, p<0.001), last HCT before CPB (31% vs 36%, p<0.001), and
first HCT measured on CPB (23% vs 28%, p<0.001). Transfused patients were also less likely
to receive blood conservation therapies such as ANH volume (8.1% vs 17.2%, p<0.001), and
autologous CPB circuit priming (77% vs 80.8%, p<0.001). Additionally, the transfusion group
received significantly larger indexed amounts of asanguineous crystalloid volume via anesthesia
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intravenous infusion (11.79 ml/kg vs 10.32 ml/kg, p<0.001) and total CPB prime volume (640.6
ml/m2 vs 604.2 ml/m2, p<0.001).
Demographic and procedural variables were distributed across quartiles of crude centerlevel perioperative RBC transfusion rates (Table 2). Center-level RBC transfusion rates ranged
from 10.9 to 59.9%. The observed-to-expected (O/E) ratios for RBC transfusion were 0.71
(0.60, 0.77), 0.89 (0.82, 0.95), 1.10 (1.07, 1.24), and 1.28 (1.20, 1.52), for quartiles 1-4,
respectively. Patients in the highest quartile group were more likely to be female (27.5% vs 22%
for Q4 and Q1, respectively; p < 0.0001), undergo urgent procedures (59.9% vs 55.6% for Q4
and Q1, respectively; p < 0.0001), and receive anticoagulant medications within 48 hours of
surgery (50.5% vs 41.6% for Q4 and Q1, respectively; p < 0.0001). There were significant
differences across transfusion across quartiles with perfusion equipment and intraoperative blood
conservation techniques. Arterial pump usage (35.5%, 51.1%, 78.9%, 8.7%, p < 0.0001), Acute
normovolemic hemodilution (ANH) harvest (17.3%, 16.1%, 13.5%, 9.9%, p < 0.0001),
autologous CPB circuit priming (89.2%, 59.7%, 89.2%, 77.4%, p < 0.0001), and del Nido
cardioplegia usage (14.2%, 23.9%, 14.9%, 5.5%, p < 0.0001) were reported for Q1-Q4,
respectively.
The random effect variance and intra-class correlation coefficients (ICC) are displayed in
Table 3. The Model 1 (hospital intercepts only) random effect variance was 0.256. Model 2
(adding patient-related factors to Model 1) increased the random effect variance to 0.453. The
calculated variance for intraoperative equipment and blood conservation modalities (Model 3)
was 0.519. However, nesting of all models together (Model 4) resulted in a decrease in the
calculated variance, 0.420. The ICC from the null model was 0.072, implying that 7.2% of the
individual variation in transfusion is due to systematic differences between hospitals, while
92.8% is due to systematic differences between patients. Model 2 (ICC = 0.12), indicates that
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the residual variation (unexplained variation) in transfusion after adjusting for patient risk factors
due to hospital differences was 12%, and 88% was due to systematic differences between
patients. Model 3 (ICC= 0.136) indicates that the unexplained variation after adjusting for
intraoperative factors due to hospital differences was 13.6%, and 86.4% was due to systematic
differences between patients. The ICC from Model 4 was 0.113, implying that 11.3% of the
individual variation in transfusion after controlling for patient risk and intraoperative factors was
due to systematic differences between hospitals, and while 88.7% of the individual variation in
transfusion is due to systematic differences between patients. Similar trends were obtained for
ICC with simulation approach (0.052, 0.0618, 0.0616, 0.0636 for M1-M4, respectively).
The direct standardized hospital transfusion rate by model is illustrated in the turnip plot
(Figure 3). The turnip plot displays the coefficient of variation, defined as the ratio of the
standard deviation to the mean hospital center transfusion rate. Each dot represents a hospital
that is centered symmetrically on the horizontal axis based on RBC transfusion rate. The
coefficient of variation for each of the models were 0.33 (observed), and 0.31, 0.29, 0.40, and
0.30 for models 1-4, respectively.

Discussion
Previous literature has identified both modifiable and non-modifiable clinical factors
associated with the increased exposure to allogeneic RBC units (22-24). Conventional wisdom
suggests that differences in baseline patient risk may be the predominant drivers of differences in
center transfusion rates following CABG surgery. With this in mind, we aimed to assess the
contributions that pre- and intraoperative factors have in explaining hospital variation in blood
transfusion rates. In this large, contemporaneous, multi-center study, we found that the addition
of intra-operative factors known at the time of transfusion decision-making did not appreciably
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improve our understanding of determinants of variation in RBC transfusion during CABG
surgery.
The turnip plot, first utilized in the Dartmouth Atlas of Health Care reports, illustrates the
dispersion of hospital transfusion variation around the mean rates (25). Only small differences in
variation were observed across each of the covariate-adjusted models. When all of the covariates
were taken account (model 4), the coefficient of variation decreased. The ICC and random
effects variance tests measured the relatedness of transfusions between hospitals. Even after
adjusting for many of the patient and procedural factors that are reported to be associated with
RBC exposure (20), there was little conformity in transfusion rates among hospitals. Guidelines
for interpreting the ICC reported by Koo & Li recommend that values less than 0.5 are indicative
of poor reliability (26). Our results indicate that the clinical factors we believed were key
determinants in transfusion decisions did not explain the variability in RBC transfusions between
hospitals. Additional investigation into nonclinical factors (e.g., provider transfusion triggers,
organizational culture, blood management protocols) may improve our understanding of centerlevel differences (27).
In an observational cohort of 102,470 patients from 798 clinical sites undergoing isolated
CABG surgery, Bennett-Guerrero et al reported significant variation in hospital risk-adjusted
transfusion rates according to geographic location (p=0.007), academic status (p=0.03), and
hospital volume (p<0.001) (15). Although these factors only attributed for 11.1% of the
observed variance, procedural case mix accounted for only 20% of the total variation. Likosky
et al examined regional-specific discretionary (1-2 units) RBC transfusions for isolated CABG
procedures across five regional cardiac surgical quality collaboratives (The IMPROVE Network)
(28). The analysis included 11,200 patients across the 56 participating centers who received 0,1,
or 2 units of RBCs during the index admission. Significant variation in RBC units and volume
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was observed across regions and remained so after pre- and intraoperative risks (9.1% - 31.7%,
p<0.001) (28). These findings suggest differences in regional transfusion practices.
Organizational culture, broadly defined as the basic assumptions and values that guide
organizations (29), may be associated with variances in clinical practice. Using multilevel
mixed-effect logistic and linear regression models, Jin et al examined variation in blood
transfusion practices among 5,744 isolated CABG procedures performed by 42 surgeons at 12
hospitals within the same health system (30). Observed variances in RBC transfusions at the
hospital level (0.82) were over twice as high as surgeons practicing at the same hospital (0.35),
suggesting a correlation between organizational culture and transfusion practice through factors
such as team familiarity, quality improvement and data sharing, and standardized clinical
practices (30). Likosky et al compared perioperative RBC transfusion rates for both CABG and
percutaneous coronary intervention (PCI) at 33 Michigan cardiac surgical programs (31). (32)A
total of 16,568 CABG and 94,634 PCI patients were included for analysis. There was wide
variation in transfusion rates observed across centers for both CABG (26.5% to 71.3%) and PCI
(1.6% to 6.0%). While perhaps somewhat surprising, the investigators found that an institution’s
CABG transfusion rate significantly correlated with the PCI rate (31). These findings suggest
that factors beyond patient-level risk may help explain center-level differences in transfusion
practices.
A number of studies have evaluated the association between clinical providers and RBC
transfusions. A retrospective single center analysis of 4,823 patients by Cote et al found that
differing practice patterns among cardiac surgeons and anesthesiologists were independent
predictors of perioperative transfusion (23). Significant differences in perioperative transfusion
rates were reported between surgeons (32.4% to 51.5%, P<.0001), anesthesiologists (34.4% to
51.9%, P<.0001), and year of hospital admission (28.2% in 2004 to 48.8% in 2008, P<.0001).
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Differences in transfusion rates among practitioners were found after adjustment for baseline and
intraoperative covariates (23). Previous surveys conducted among critical care practitioners
reported significant individual variation in acceptable hemoglobin concentrations prior to
transfusion (33, 34). While differences in transfusion triggers may be attributed to patientrelated clinical factors, physicians may weigh these clinical characteristics differently in the
absence of formal institutional protocols. Clinical transfusion triggers may also be influenced by
environmental factors such as computer decision support, motivation to adopt guidelines, and
support for colleagues (35).
Despite the reported benefits of team familiarity on clinical effectiveness and surgical
teamwork (36-38), its association with blood transfusion behaviors has not been previously
described. Shared work experiences and familiarity among team members has been reported to
contribute to improved anticipation, coordination, and productivity (39). Conversely, clinicians
that experience a high level of dispersion across larger and unfamiliar teams may lack the bonds
and interpersonal relationships for effective collaboration. Poor communication between
unfamiliar team members may lead to avoidable transfusions, as team members may not
compensate for unfamiliarity with increased communication (40). These effects may be
exacerbated by increased staff turnover, surgical case volume, and education. It is conceivable
that centers with fewer team member combinations can establish a quicker consensus regarding
transfusion best practices. Decisions among intraoperative care members are improved with
teamwork and experience (41, 42). Although we reported the number unique staffing pairs
among surgeons and perfusionists (Table 2), we were unable to capture anesthesia personnel.
This data may have provided a more reliable estimate of explanatory transfusion variation within
and across centers.
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Although single and multi-center studies have reported reductions in potentially
discretionary transfusions through programmatic guideline development, education, and
feedback/audit activities (43-46), these activities are not considered mandatory research
reporting criteria (20). Our findings highlight the importance of identifying and comparing
programmatic differences in blood management. Such variables may include the presence of
transfusion triggers, protocols, and institutional blood management committees. Variability in
practice may exist in circumstances when multiple clinicians are empowered to make transfusion
decisions. Differences in clinical opinion combined with multiple triggers may not support
standardized transfusion algorithms. The single-center experience of Cote and colleagues
describes a joint process on intraoperative transfusion decisions that collectively involve the
surgeon, anesthesiologist and perfusionist (23). However, once the patient is admitted to the
postoperative care arena it was predominately the surgeon who decides. The incorporation of
these practices is not currently captured in clinical outcome registries.
There were several limitations to our study. First, as in any observational cohort study,
we cannot rule out the impact of unmeasured confounding. Nonetheless, we adjusted for
commonly reported risk factors associated with the risk of transfusion (18). Additionally, our
analysis was restricted to variables that are known prior to the initiation of CPB support and
before a transfusion decision is made. Second, there may also be potential collinearity among
the model covariates that could influence the regression coefficient. For example, net CPB
prime volume was included in the intraoperative procedural model and is a function of the
difference between CPB static prime volume (in ml) and autologous blood prime volume (in
ml). As such, we removed the autologous CPB prime volume from the model as a separate
covariate. All attempts were made to omit any of the independent variables that demonstrated
strong correlation. Third, we recognize that our findings are generalizable only to the institutions
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participating in the PERForm registry. Last, we recognize that we are unaware of the primary
reasons underlying RBC transfusions across centers. Observational research may be limited in
capturing the appropriate circumstances associated with transfusion medicine.
In summary, our analysis was unable to explain the majority of perioperative RBC
transfusion variation across centers performing CABG surgery. Variation across hospitals could
not be explained by conventional patient and procedural factors present at the time of transfusion
decision. Further investigation is warranted to consider the impact of human factors and the nontechnical aspects of transfusion medicine. The degree to which institutions adopt transfusion
algorithms is relatively unknown. Clinical guidelines that are not uniformly applied will
continue to influence local hospital decisions and have limited effect on individual provider
practices. Changes in organizational culture and reporting are necessary to help ensure the
transfusion decisions we make are the right ones.
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Figure 1. Selection criteria for study population inclusion

Isolated CABG
22,487 patients (July 2011-July 2017)

Isolated CABG for RBC prediction
22,444 patients

Isolated CABG
22,272 patients for analysis

Exclude patients with duplicate
record ID and participant ID
(n=43)

Exclude patients with unplanned CPB
and who refuse transfusion. (Jehovah’s
Witness)
(n=172)
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Figure 2. Multivariable Logistic Regression Models of RBC Transfusion Variables
Model 1
Model 2

Model 3

Model 4

Description
Hospital random intercepts only

Covariates
None

Model 1 + Patient demographic,
laboratory assay results, and
preoperative risk factors

-

Model 1 + Perfusion Factors
(Intraoperative Blood
Conservation Procedural Factors)

(Hospital random intercepts) +
(Patient demographic, laboratory
assay results, and preoperative
risk factors) + (Intraoperative
Blood Conservation Procedural
Factors)

-

Model 1
Age (years)
Body Surface Area (m2)
Sex (M/F)
Admission status (elective, urgent,
emergent/salvage)
Preoperative Hematocrit (%)
Serum Albumin (g/dl)
Serum Creatinine (mg/dl)
Platelet count (x 10,000)
Current smoker (y/n)
Chronic lung disease (y/n)
Previous MI (y/n)
Congestive Heart Failure (y/n)
Cardiogenic Shock (y/n)
Peripheral Vascular Disease (y/n)
Cerebrovascular disease (y/n)
Diabetes Mellitus (y/n)
Dialysis (y/n)
Hypertension (y/n)
Anticoagulant medications <48 hrs (y/n)
Reoperative status (y/n)
Number of diseased vessels
Model 1
Arterial Roller Pump Use (y/n)
Acute Normovolemic Hemodilution (ANH)
(y/n)
del Nido cardioplegia use (y/n)
Autotransfusion use (y/n)
Autologous CPB circuit prime (y/n)
Indexed Net CPB Prime (ml/m2)
Model 1
Model 2
Model 3
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Table 1. Descriptive Statistics of Patient and Procedural Variables According to Perioperative
RBC Transfusion.

Intraoperative Only
Postoperative transfusion only
Intraoperative & Postoperative
Intraoperative CPB equipment
Roller pump
Cardioplegia
CDPG (non-del Nido)
del Nido only
None
Autotransfusion device
Demographics
Age (years)
BSA (m2)
Female
Admission status
Elective
Urgent
Emergent/emergent salvage
Lab values
Preoperative HCT (%)
Total albumin (g/dl)
Last creatinine (mg/dl)
Platelets count (x 10000)
Intraoperative blood conservation
techniques
1st HCT on CPB support
Last HCT prior to CPB
Anesthesia crystalloid volume
(indexed to pt. kg weight) (ml/m2)
Static prime volume (indexed to
BSA) ml/m2
Total prime volume (indexed to BSA)
ml/m2
Autologous Circuit Prime (count, %)

Perioperative RBC transfusion
Transfusion
Transfusion
Overall
(No)
(yes)
22272
15031
7241
1586
0 (0.0)
1586 (21.9)
3884 (17.4)
0 (0.0)
3884 (53.6)
1771
0 (0.0)
1771 (24.5)
9914 (44.5)

6771 (45.0)

3143 (43.4)

18606 (83.5)
3250 (14.6)
416 (1.9)
18978 (85.2)

12474 (83.0)
2311 (15.4)
246 (1.6)
12727 (84.7)

6132 (84.7)
939 (13.0)
170 (2.3)
6251 (86.3)

65 [58, 72]
2.03 [1.87,
2.18]
5398 (24.2)

64 [57, 71]
2.07 [1.93,
2.21]
2391 (15.9)

68 [61, 75]
1.93 [1.77,
2.09]
3007 (41.5)

8825 (39.6)
12834 (57.6)
611 (2.7)

6326 (42.1)
8413 (56.0)
291 (1.9)

2499 (34.5)
4421 (61.1)
320 (4.4)

40 [36, 43]
3.80 [3.50,
4.10]
1.00 [0.80,
1.19]
20.80 [17.30,
25.00]

41 [38., 44]
3.80 [3.60,
4.10]
0.97 [0.80,
1.10]
20.70 [17.30,
24.60]

36 [32, 39]
3.70 [3.30,
4.00]
1.00 [0.80,
1.30]
21.00 [17.00,
26.00]

27.00 [23.00,
31.00]
35.00 [31.00,
39.00]
10.74 [7.53,
14.77]
1000.00
[900.00,
1220.00]
614.10
[506.22,
722.91]
17714 (79.5)

28.00 [25.00,
32.00]
36.00 [33.00,
40.00]
10.32 [7.30,
14.10]
1050.00
[900.00,
1220.00]
604.24
[498.32,
704.35]
12141 (80.8)

23.00 [21.00,
27.00]
31.00 [27.00,
35.00]
11.79 [8.11,
16.50]
1000.00
[850.00,
1250.00]
640.61
[525.15,
766.03]
5573 (77.0)

Significance
(p< 0.05)

<0.001

0.022
<0.001

0.001
<0.001
<0.001
<0.001
<0.001

<0.001
<0.001
<0.001
<0.001

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
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Autologous circuit volume (ml)
Acute normovolemic hemodilution
(ANH)
ANH volume (ml) [among ANH
(yes)]
Patient Risk factors
Current smoker
Previous MI
Severe/moderate chronic lung disease
CHF
no
yes
unknown
PVD
no
yes
unknown
Diabetes
Cardiogenic shock
CVD
Preoperative dialysis
Hypertension
Anticoagulant use (<48 hrs)
First cardiovascular surgery
Number of diseased vessels (3 or
more)

500.00
[200.00,
625.00]

500.00
[250.00,
650.00]

450.00
[200.00,
600.00]

<0.001

3176 (14.3)

2591 (17.2)

585 (8.1)

<0.001

5.8 [4.6,8.2]

5.8 [ 4.7, 8.8]

5.8 [4.4, 6.2]

<0.001

5006 (22.5)
12094 (54.3)
2264 (10.2)

3575 (23.8)
7744 (51.5)
1285 (8.5)

1431 (19.8)
4350 (60.1)
979 (13.5)

<0.001
<0.001
<0.001
<0.001

17058 (76.6)
2491 (11.2)
2723 (12.2)

12381 (82.4)
1439 (9.6)
1211 (8.1)

4677 (64.6)
1052 (14.5)
1512 (20.9)
<0.001

16633 (74.7)
2914 (13.1)
2725 (12.2)
10543 (47.3)
382 (1.7)
4673 (21.0)
562 (2.5)
19970 (89.7)
10287 (46.2)
21772 (97.8)

12074 (80.3)
1745 (11.6)
1212 (8.1)
6743 (44.9)
140 (0.9)
2614 (17.4)
112 (0.7)
13290 (88.4)
6617 (44.0)
14783 (98.4)

4559 (63.0)
1169 (16.1)
1513 (20.9)
3800 (52.5)
242 (3.3)
2059 (28.4)
450 (6.2)
6680 (92.3)
3670 (50.7)
6989 (96.5)

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

17462 (78.4)

11598 (77.2)

5864 (81.0)

<0.001

Continuous variables expressed as median, [IQR], and categorical variables as count (%).
CDPG indicates cardioplegia; BSA, body surface area; HCT, hematocrit; CPB, cardiopulmonary
bypass; MI, myocardial infarction; CHF, congestive heart failure; PVD, peripheral vascular
disease; CVD, cerebrovascular disease.
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Table 2. Distribution of Demographic Variables According to Quartiles of Center-level
Perioperative RBC Transfusion Rates.
Perioperative RBC
transfusion rates (%)
Patients (n)
Hospitals (n)
Surgeons (n)
Perfusionists (n)
Unique pairs of surgeons
and perfusionists
O/E Ratio of RBC
Transfusion
Age (years)
Sex (Female- %)
Body Surface Area

(m2)

Elective Operative Status
(%)
Elective
Urgent
Emergent/emergent
salvage
Number of Diseased
Vessels (>3)
Previous Myocardial
Infarction (%)
Reoperative Status (%)
Diabetes Mellitus (%)
Cerebrovascular Disease
(%)
Congestive Heart Failure
(%)
Cardiogenic Shock (%)
Peripheral Vascular
Disease (%)
Smoking (%)
Chronic Lung Disease (%)
Hypertension (%)
Dialysis (%)
Left Ventricular Ejection
Fraction (%)
Preoperative Hematocrit
(%)
Platelet Count (per µl)
Anticoagulant medications
(< 48 hrs) (%)
Creatinine (mg/dl)
Albumin (g/dl)
Arterial Roller Pump Use
(%)
Del Nido Cardioplegia
Use (%)

Overall
10.9-59.9
22272
43
209
294

Q1
10.9-23.6
5807
10
61
68

Q2
24.2-31.2
5178
11
40
63

Q3
33.0-39.8
6005
11
57
74

Q4
40.0-59.9
5282
11
51
89

1421

336

314

460

407

0.98 (0.80,
1.23)

0.71 (0.60,
0.77)

0.89 (0.82,
0.95)

1.10 (1.07,
1.24)

1.28 (1.20,
1.52)

65.0
(58.0,72.0)
24.2
2.0
(1.9, 2.2)

65.0
(58, 72)
22
2.0
(1.9, 2.2)

66.0
(59, 73)
23.3
2.0
(1.9, 2.2)

65.0
(58, 72)
24.4
2.0
(1.9, 2.2)

65.0 (57.0,
72)
27.5
2.0
(1.8, 2.2)

Significance
(p<0.05)

<.0001
<.0001
<.0001
<.0001

39.6
57.6
2.7
78.4
54.3
2.2
47.3
21.0
11.2
1.7
13.2
22.5
10.2
89.7
2.5
55.0
(45.0,60.0)
39.9 (36.0,
43.0)
208 (172,
251)

41.7
55.6

35.5
61.4

43.4
54.4

37.1
59.9

2.7

3.1

2.3

3

78.8

78.6

78.1

78.1

0.72

55.1
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51.9

56.5

<.0001

2.3
47.2

2.8
45.1

1.7
46.5

2.3
50.5

0.0011
<.0001

18.7

23.6

20

22.1

<.0001

10.4

10.5

12.4

11.4

<.0001

1.5

1.8

1.8

1.8

0.45

11.7

13.6

12.2

15.1

<.0001

20.9
9.9
88.6
2.3
55.0
(45.0,60.0)
40.0 (36.0,
43.0)
209 (173,
250)

20.3
9.5
87.9
2.2
55.0
(47.0,60.0)
39.9 (36.0,
42.8)
205 (171,
246)

22.9
9.1
90.1
2.6
55.0
(45.0,60.0)
39.7 (35.9,
42.9)
209 (173,
253)

25.9
12.3
92.1
3.1
55.0
(45.0,60)
39.3
(35.2, 42.8)
209 (171,
255)

<.0001
<.0001
<.0001
0.016

<.0001

<.0001
<.0001

46.2
1.0
(0.8, 1.2)
3.8
(3.5, 4.1)

41.6

43.3

49.4

50.5

1.0
(0.8, 1.1)
3.8
(3.6, 4.1)

1.0
(0.8, 1.2)
3.8
(3.4, 4.1)

1.0
(0.8, 1.2)
3.8
(3.4, 4.0)

1.0
(0.8, 1.2)
3.8
(3.5, 4.1)

44.5

35.5

51.1

78.9

8.7

<.0001

14.6

14.2

23.9

14.9

5.5

<.0001

<.0001
<.0001
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Autotransfusion Usage
(%)
Acute Normovolemic
Hemodilution (y/n)
Acute Normovolemic
Hemodilution (ml)
Autologous Blood CPB
Prime (RAP)
Autologous Blood Prime
(ml)
Static CPB prime, indexed
to BSA (ml/m2)
Net Prime Volume,
Indexed to BSA (ml/m2)
Last Pre-CPB Hematocrit
(%)

85.2

94.44

59.77

90.56

93.92

<.0001

14.3

17.3

16.1

13.5

9.9

<.0001

450
(400, 900)

800
(400, 900)

500
(450, 900)

450
(400, 450)

350
(350, 450)

<.0001

89.2

59.7

89.2

77.4

<.0001

600
(400, 650)
1200
(900,1215)
373.7
(262.4,505.1)

500
(400, 600)
1000
(900,1200)
434.8
(286.7,640.1)

600
(400, 750)
1100
(900,1500)
366.5
(250.6,483.7)

600
(400, 700)
1000
(850, 1220)
331.9
(233.3,456.9)

35 (31,38)

36 (32, 39)

35 (30, 39)

35 (30, 38)

79.5
550
(400, 700)
1000
(900,1220)
371.9
(258.5,514.3)
35.0 (31.0,
39.0)

Continuous variables expressed as median, [IQR], and categorical variables as count (%).

<.0001
<.0001
<.0001
<.0001
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Table 3. Random effect variance and ICC coefficient model results
Model 1
(Hospital
intercepts only)

Random Effects
Variance
ICC coefficient
with latent
variable
approach
ICC coefficient
with simulation
approach

0.256

Model 2
(Model 1 +
Patient
demographic,
laboratory assay
results, and
preoperative risk
factors
0.453

0.072

0.052

Model 3
(Model 1 +
Intraoperative
Blood
Conservation
Procedural
Factors

Model 4
(Model 1 +
Model 2 +
Model 3)

0.519

0.420

0.12

0.136

0.113

0.062

0.062

0.064
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Figure 3. Turnip Plot of Direct Standardized Hospital Transfusion Rates by Models
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FIGURES AND TABLES

Figure 1: Early and Late Complications reported from Blood Transfusions (adapted from
Maxwell & Wilson, 2006)
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Figure 2: The effect of preoperative anemia on postoperative outcome (Loor et al, 2012)
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Figure 3: Adverse events and anemia management. (Loor et al, 2012)
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Figure 4: Restrictive vs Liberal Transfusion in Cardiac Surgery (Shehata et al, 2019)
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Figure 5. Selection criteria for study population inclusion

Isolated CABG
22,487 patients (July 2011-July 2017)
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Table 1: Multivariable Logistic Regression Models of RBC Transfusion Variables
Model 1
Model 2

Model 3

Model 4

Description
Hospital random intercepts only

Covariates
None

Model 1 + Patient demographic,
laboratory assay results, and
preoperative risk factors

-

Model 1 + Intraoperative Blood
Conservation Procedural Factors

(Hospital random intercepts) +
(Patient demographic, laboratory
assay results, and preoperative
risk factors) + (Intraoperative
Blood Conservation Procedural
Factors)

-

Model 1
Age (years)
Body Surface Area (m2)
Sex (M/F)
Admission status (elective, urgent,
emergent/salvage)
Preoperative Hematocrit (%)
Serum Albumin (g/dl)
Serum Creatinine (mg/dl)
Platelet count (x 10,000)
Current smoker (y/n)
Chronic lung disease (y/n)
Previous MI (y/n)
Congestive Heart Failure (y/n)
Cardiogenic Shock (y/n)
Peripheral Vascular Disease (y/n)
Cerebrovascular disease (y/n)
Diabetes Mellitus (y/n)
Dialysis (y/n)
Hypertension (y/n)
Anticoagulant medications <48 hrs (y/n)
Reoperative status (y/n)
Number of diseased vessels
Model 1
Arterial Roller Pump Use (y/n)
Acute Normovolemic Hemodilution (ANH)
(y/n)
del Nido cardioplegia use (y/n)
Autotransfusion use (y/n)
Autologous CPB circuit prime (y/n)
Indexed Net CPB Prime (ml/m2)
Model 1
Model 2
Model 3

